Centre for Eye and Vision Research Limited
Hong Kong, Guangdong, 00000
Location status: Recruiting
NCT Number: NCT05913063
Age-related macular degeneration (AMD), is a debilitating eye disease that causes a loss of central vision. The prevalence of AMD increases exponentially with age and causes a significant impact through both medical expenses and the social and economic costs associated with vision loss. AMD is the global leading cause of blindness among people over the age of 60. Detection of this eye disease at early stages coupled with prompt treatment can prevent vision loss; however, modern diagnosis methods are ineffective at diagnosis of AMD before vision loss occurs. While a range of available treatment options has been effective at slowing vision loss due to AMD, no treatment exists which can recover lost vision. The investigators propose to apply tools developed in quantum information science to diagnose AMD before vision has been affected, drastically improving health outcomes for patients with AMD.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Hong Kong, Guangdong, 00000
Location status: Recruiting
There has been tremendous progress in generating and detecting structured light which possesses advantageous propagation characteristics such as quantized orbital angular momentum (OAM), non-diffraction, and self-healing. These special beams have found applications in microscopy, encoding and multiplexing of communications, and manipulation of matter. Here the investigators bring the structured light toolbox to vision sciences for the first time and expand the space of possible stimuli.
A healthy macula possesses azimuthally ordered dichroic fibres that act as a radial polarization filter, enabling a typical person to perceive linearly polarized light through the entoptic phenomena known as Haidinger's brushes. Despite significant interest in the application of this phenomenon to the detection of age-related macular degeneration, no device has currently seen widespread adoption in a clinical environment. This is due to the difficulty in observing Haidinger's brush, the imprecise measurements that this test can extract, and the difficulty in instructing patients during these tests.
Leveraging the quantum-inspired toolbox developed in the field of structured light, the investigators can project polarization-coupled OAM states of light directly on a person's retina. This enables the investigators to create arbitrary entoptic patterns in a person's vision based on the structure and chemical composition of their subjective macula, and the investigators have the opportunity to develop a litany of novel diagnostic tests to characterize and quantify the health of the macula.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Conducting the psychophysical task on the perception of OAM-coupled polarized light created using the experimental setup - Structured Light Imaging Microscopy (SLIM). Four types of vortex orbital angular momentum, differing by the number of fringes l=5;10; 15;20, will be presented for 0.5s per trial during which an azimuthally varying entoptic profile rotated clockwise or counterclockwise. A circular mask with a varying radius will be placed at fixation, thus the task will be performed at varying eccentricities. Circular obstruction of the area will be achieved due to the high refresh-rate structured light modulator. The threshold mask size will be changed by a 2up/1down staircase method (71% accuracy for the estimation of mask size).
Time frame: Approximately 10 minutes, Screening and Training day (Session 1)
Assessment of the participant's ability to see the entoptic phenomena created using the structured light (SL) - orbital angular momentum (OAM) coupled polarized light. Various SL vortex and radial patterns will be projected using the custom research-based laser optical setup
Time frame: Approximately 30 minutes, on the completion of the study (Session 6)
Calculation of the radius of the central obstruction. From a total of 14 reversal trials, the six last values of the mask size will be used for the calculation of the threshold mask size mean (r mean). The standard deviation will be computed from the variance of these last six trials
Time frame: Approximately 10 minutes, Screening and Training day (Session 1)
Measurement of the retinal layers' thickness and total neuroretina
Time frame: Approximately 5 minutes, Screening and Training day (Session 1)
Computer-based measurement of contrast sensitivity
Time frame: Approximately 5 minutes, Screening and Training day (Session 1)
Imaging the retina using white light. The diameter of the optic nerve head will be measured in order to calculate the degree/pixel ratio for each participant
Time frame: Approximately 5 minutes, Screening and Training day (Session 1)
Measurement of the central corneal thickness and axial eye length
Time frame: Approximately 10 minutes, Screening and Training day (Sessions 1 and 2)
Computer-based measurement of the macular pigment optical density (MPOD)
Contact information is provided by the study sponsor or research team.
Benjamin Thompson, PhD
CONTACT
Mukhit Kulmaganbetov, MD, PhD
CONTACT
Centre for Eye and Vision Research
Other
Direct Discrimination of Quantum States by the Human Eye With Macular Degeneration
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07440225
Age-Related Macular Degeneration, Choroid Diseases
Scottsdale, Arizona, United States
View Trial DetailsNCT07496567
Age-Related Macular Degeneration, Choroid Diseases
Gilbert, Arizona, United States
View Trial DetailsNCT06662162
Age-Related Macular Degeneration, Age-Related Macular Degeneration (ARMD)
Manchester, Connecticut, United States
View Trial DetailsNCT06237127
Age-Related Macular Degeneration, Eye Diseases
Sacramento, California, United States
View Trial Details